News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
219 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (23384)
Month
January (2722)
February (2862)
March (3369)
April (3287)
May (3419)
June (3649)
July (3258)
August (3461)
September (3585)
October (3789)
November (3817)
December (2398)
Day
1 (226)
2 (276)
3 (249)
4 (273)
5 (204)
8 (210)
9 (242)
10 (232)
11 (219)
12 (172)
15 (209)
16 (194)
17 (163)
18 (152)
19 (107)
22 (127)
23 (138)
24 (101)
29 (156)
30 (167)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
24
29
30
Business
Furiex Pharmaceuticals, Inc. Reports Third Quarter 2010 Financial Results
November 11, 2010
·
1 min read
Drug Development
Incyte Corporation’s Selective Oral JAK1 and JAK2 Inhibitor Demonstrates Positive Phase IIa Results in Patients with Active Rheumatoid Arthritis
November 11, 2010
·
1 min read
Business
4SC AG Reports First Nine Months Financial Results 2010
November 11, 2010
·
1 min read
Business
Meridian Bioscience, Inc. Reports Fourth Quarter and Full-Year Fiscal 2010 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2011 Guidance
November 11, 2010
·
1 min read
Genetown
Synta Pharmaceuticals Reports Sale of $5 Million in Common Stock to Member of Synta Board of Directors
November 11, 2010
·
1 min read
Business
Ondine Biomedical Inc. Announces Third Quarter 2010 Financial Results
November 11, 2010
·
26 min read
Business
Titan Spine Appoints Andrew Shepherd Vice President of Marketing
November 11, 2010
·
1 min read
BioCapital
Micromet Announces Pricing of Public Offering of 9.9 Million Shares of Common Stock
November 11, 2010
·
1 min read
Pharm Country
iCAD, Inc. to Present at Maxim Group Growth Conference
November 11, 2010
·
1 min read
Biotech Beach
ImmunGene’s Pipeline of Next Generation Cancer Therapeutics Featured in BioWorld Today
November 11, 2010
·
2 min read
Previous
5 of 22
Next